TrialEuropean journal of ophthalmology2018

A 12-month, multicenter, parallel group comparison of dexamethasone intravitreal implant versus ranibizumab in branch retinal vein occlusion.

Francesco Bandello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.